EG
Emkay Global Financial Services
VerifiedMarket analysis from this source
Track record
Building a track record
Graded calls
0 hit · 0 miss
Pending
16 awaiting resolution
Recent analysis
Newest first. Every call links back to its original source.
| Call | Instrument | Verdict | Actions |
|---|---|---|---|
| “A 25 basis point RBI rate hike in October appears likely, initiating a shallow hiking cycle of 50-75 basis points. This …” | Indian Government Bonds | PENDING | |
| “Maintained a 'Buy' call on Paytm, raising its target price to ₹2,400. The new UPI MDR framework replaces the earlier dis…” | Paytm | PENDING | |
| “Estimates Pine Labs' FY28 UPI MDR revenue at Rs 1.55 billion. The discounted value of this revenue stream could add Rs 5…” | Pine Labs | PENDING | |
| “Bullish on Paytm's long-term value, estimating FY28 UPI MDR revenue of Rs 11.2 billion. The discounted value of this rev…” | Paytm | PENDING | |
| “Maintains a 'Buy' call on Pine Labs, increasing its target price to ₹230. The new UPI acquiring model, with its contract…” | Pine Labs | PENDING | |
| “Maintains a 'Buy' call on Paytm, increasing its target price to ₹2,400, implying around 39% upside potential. The new UP…” | Paytm | PENDING | |
| “Retains 'buy' rating on SBI, revising the target price to ₹1,350. The firm anticipates healthy broad-based growth, suppo…” | SBI | PENDING | |
| “Maintained an 'Add' rating on Titan Company with a target price of ₹5,600, believing the company has eased concerns abou…” | Titan Company | NOT GRADED | |
| “Maintains a 'BUY' rating on Park Medi World, revising its June-27 price target up by 7% to ₹375 from ₹350, based on 21x …” | Park Medi World | PENDING | |
| “Bullish on SBI Funds Management, initiating coverage with a 'Buy' rating and a target price of ₹750 by June 2027. This s…” | SBI | PENDING | |
| “Upgraded Mahindra Finance to 'buy' from 'add', raising the target price by 18.4% to ₹450, implying a 29% upside potentia…” | Mahindra & Mahindra Financial Services | PENDING | |
| “Initiated coverage on SBI Funds Management with a 'Buy' recommendation and a target price of ₹750 per share, implying a …” | SBI | PENDING | |
| “Initiated coverage on SBI Funds Management shares with a 'Buy' call and a target price of ₹750, implying a 31% upside fr…” | SBI | PENDING | |
| “Emkay Global initiated coverage on SBI Funds Management with a 'Buy' rating and a price target of ₹750 per share, implyi…” | SBI | PENDING | |
| “Retained a Buy rating on Reliance Industries with a target price of ₹1,680, implying a 27% upside. Q1FY27 consolidated E…” | Reliance Industries | PENDING | |
| “Initiated coverage on Kusumgar shares with a 'Buy' rating and a target price of ₹800. The positive stance is driven by s…” | Kusumgar | PENDING | |
| “Neutral on TCS, noting that while its valuation at 13x FY27 price-to-earnings is undemanding after a 40% drop from its 5…” | TCS | PENDING | |
| “Reiterates 'Add' rating on TCS with a target price of ₹2,600, implying a nearly 27% upside. Despite a soft Q1 performanc…” | TCS | NOT GRADED | |
| “Bullish on Vedanta Aluminium with a 'Buy' call and a target price of Rs 550, implying a 24% upside. Analysts believe the…” | Vedanta Aluminium | NOT GRADED |
By instrument
Graded calls broken down by what was being called.
Indian Government Bonds
1 pending
Paytm
3 pending
Pine Labs
2 pending
SBI
5 pending
Titan Company
0 pending
Park Medi World
1 pending
Mahindra & Mahindra Financial Services
1 pending
Reliance Industries
1 pending
Kusumgar
1 pending
TCS
1 pending
Vedanta Aluminium
0 pending